Tech Company Financing Transactions

Alimera Sciences Funding Round

Alimera Sciences closed a $5 million funding round on 9/30/2009. Investors included Domain Associates, Intersouth Partners and Polaris Partners.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

6120 Windward Pkwy. 290
Alpharetta, GA 30005
USA

Phone

(678) 990-5740

Website

www.alimerasciences.com

Email Address

[email protected]

Overview

Biopharmaceutical company that researches, develops and commercializes prescription ophthalmic pharmaceuticals with a focus on the back of the eye, or retina.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Rick Eiswirth

        

Chief Financial Officer

Philip Jones

        

Chief Medical Officer

Samer Kaba

        

Chief Operating Officer

Philip Ashman

        

VP - Marketing

Dave Holland

        

Browse more venture capital transactions:

Prev: 9/30/2009: PowerFile venture capital transaction
Next: 9/30/2009: Return Path venture capital transaction

Share this article

Where The Data Comes From

We record all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary